Cross-sectional Study to Assess Ocular Surface and Tear Film Status in Patients on Topical Antiglaucoma Therapy

Aim and background: To assess ocular surface and tear film status in patients on topical antiglaucoma medication. When monotherapy proves insufficient, polytherapy and drug combinations are used. Long-term use of multiple topical medications is correlated with ocular irritation and tear film instabi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jayshri B Pandhre, Sanjiv Agrawal, Radhika Umale, Amogha U Mahale
Format: Article
Language:English
Published: Jaypee Brothers Medical Publisher 2025-06-01
Series:Journal of Medical Academics
Subjects:
Online Access:https://www.jmaacms.com/doi/JOMA/pdf/10.5005/jp-journals-11003-0160
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849392704317816832
author Jayshri B Pandhre
Sanjiv Agrawal
Radhika Umale
Amogha U Mahale
author_facet Jayshri B Pandhre
Sanjiv Agrawal
Radhika Umale
Amogha U Mahale
author_sort Jayshri B Pandhre
collection DOAJ
description Aim and background: To assess ocular surface and tear film status in patients on topical antiglaucoma medication. When monotherapy proves insufficient, polytherapy and drug combinations are used. Long-term use of multiple topical medications is correlated with ocular irritation and tear film instability. Materials and methods: This observational cross-sectional study involved 81 eyes from 43 patients receiving antiglaucoma medications. Among them, 18 patients (<i>n</i> = 34) were using single medications, while 25 patients (<i>n</i> = 47) were on two or more medications. The assessment included corneal staining with fluorescein, impression cytology of the conjunctiva, the Schirmer test, and tear film break-up time (TBUT). Results: The percentage of ocular surface alterations varied from 9 to 70%, and abnormal tear film status varied from 32 to 72%. The subjects in the polytherapy group had higher corneal staining (70 vs 47%, <i>p</i> = 0.0354, significant) and abnormal (72 vs 59%, <i>p</i> = 0.0005, significant). The percentage of abnormal impression cytology reports (9 vs 4%, <i>p</i> = 0.4804) and Schirmer test results were almost equal in both groups. Conclusion: Ocular surface disorders (OSD) are more common in polytherapy, as they are in all antiglaucoma medication users. However, the tear film status is more significantly affected in subjects on polytherapy.
format Article
id doaj-art-832da77fdef847ee925e94c7c0bfb9cc
institution Kabale University
issn 2581-8279
language English
publishDate 2025-06-01
publisher Jaypee Brothers Medical Publisher
record_format Article
series Journal of Medical Academics
spelling doaj-art-832da77fdef847ee925e94c7c0bfb9cc2025-08-20T03:40:43ZengJaypee Brothers Medical PublisherJournal of Medical Academics2581-82792025-06-0181111510.5005/jp-journals-11003-01604Cross-sectional Study to Assess Ocular Surface and Tear Film Status in Patients on Topical Antiglaucoma TherapyJayshri B Pandhre0https://orcid.org/0009-0009-4788-6041Sanjiv Agrawal1Radhika Umale2Amogha U Mahale3https://orcid.org/0009-0008-5367-6350Jayshri B Pandhre, Department of Ophthalmology, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, Maharashtra, India, Phone: +91 9689067208Department of Ophthalmology, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, Maharashtra, IndiaDepartment of Ophthalmology, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, Maharashtra, IndiaDepartment of Ophthalmology, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, Maharashtra, IndiaAim and background: To assess ocular surface and tear film status in patients on topical antiglaucoma medication. When monotherapy proves insufficient, polytherapy and drug combinations are used. Long-term use of multiple topical medications is correlated with ocular irritation and tear film instability. Materials and methods: This observational cross-sectional study involved 81 eyes from 43 patients receiving antiglaucoma medications. Among them, 18 patients (<i>n</i> = 34) were using single medications, while 25 patients (<i>n</i> = 47) were on two or more medications. The assessment included corneal staining with fluorescein, impression cytology of the conjunctiva, the Schirmer test, and tear film break-up time (TBUT). Results: The percentage of ocular surface alterations varied from 9 to 70%, and abnormal tear film status varied from 32 to 72%. The subjects in the polytherapy group had higher corneal staining (70 vs 47%, <i>p</i> = 0.0354, significant) and abnormal (72 vs 59%, <i>p</i> = 0.0005, significant). The percentage of abnormal impression cytology reports (9 vs 4%, <i>p</i> = 0.4804) and Schirmer test results were almost equal in both groups. Conclusion: Ocular surface disorders (OSD) are more common in polytherapy, as they are in all antiglaucoma medication users. However, the tear film status is more significantly affected in subjects on polytherapy.https://www.jmaacms.com/doi/JOMA/pdf/10.5005/jp-journals-11003-0160antiglaucomaglaucomaocular surface diseasepreservative-freetear film
spellingShingle Jayshri B Pandhre
Sanjiv Agrawal
Radhika Umale
Amogha U Mahale
Cross-sectional Study to Assess Ocular Surface and Tear Film Status in Patients on Topical Antiglaucoma Therapy
Journal of Medical Academics
antiglaucoma
glaucoma
ocular surface disease
preservative-free
tear film
title Cross-sectional Study to Assess Ocular Surface and Tear Film Status in Patients on Topical Antiglaucoma Therapy
title_full Cross-sectional Study to Assess Ocular Surface and Tear Film Status in Patients on Topical Antiglaucoma Therapy
title_fullStr Cross-sectional Study to Assess Ocular Surface and Tear Film Status in Patients on Topical Antiglaucoma Therapy
title_full_unstemmed Cross-sectional Study to Assess Ocular Surface and Tear Film Status in Patients on Topical Antiglaucoma Therapy
title_short Cross-sectional Study to Assess Ocular Surface and Tear Film Status in Patients on Topical Antiglaucoma Therapy
title_sort cross sectional study to assess ocular surface and tear film status in patients on topical antiglaucoma therapy
topic antiglaucoma
glaucoma
ocular surface disease
preservative-free
tear film
url https://www.jmaacms.com/doi/JOMA/pdf/10.5005/jp-journals-11003-0160
work_keys_str_mv AT jayshribpandhre crosssectionalstudytoassessocularsurfaceandtearfilmstatusinpatientsontopicalantiglaucomatherapy
AT sanjivagrawal crosssectionalstudytoassessocularsurfaceandtearfilmstatusinpatientsontopicalantiglaucomatherapy
AT radhikaumale crosssectionalstudytoassessocularsurfaceandtearfilmstatusinpatientsontopicalantiglaucomatherapy
AT amoghaumahale crosssectionalstudytoassessocularsurfaceandtearfilmstatusinpatientsontopicalantiglaucomatherapy